← Back to Patent Explorer
US4452791A Expired / Lapsed US ⏱️ 0.0 years remaining

Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors

Assignee: ER Squibb and Sons LLC
•
Filing: 1982-03-15
•
Granted: 1984-06-05
•
Expires: 2002-03-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the structure ##STR1## are provided which are inhibitors of angiotensin converting enzyme and are useful in the treatment of hypertension.

Inventors

  • 👤 Denis E. Ryono
  • 👤 Edward W. Petrillo, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 18:14
CPC Classifications
C; C07; C07D; C07D209/00; C07D209/02; C07D209/44; C07D209/48; A; A61; A61P; A61P43/00; C07F; C07F9/00; C07F9/02; C07F9/28; C07F9/30; C07F9/306; C07F9/32; C07F9/3205; C07F9/3211; C07F9/3223; C07F9/3241; C07F9/3258; C07F9/3288; C07F9/48; C07F9/4808; C07F9/4816; C07F9/547; C07F9/553; C07F9/5537; C07F9/572; C07F9/5728; C07F9/576; C07F9/59; C07F9/645; C07F9/6503; C07F9/6506; C07F9/655; C07F9/65515; C07F9/6553; C07F9/655345; C07F9/6558; C07F9/6561; C07F9/65615

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 430 words
A compound of the formula ##STR309## and pharmaceutically acceptable salts thereof, wherein R 1 is lower alkyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, aminoalkyl, furyl, furylalkyl, thienyl, thienylalkyl, pyridyl, pyridylalkyl or ##STR310## and R 5 and R 6 are independently selected from hydrogen, lower alkyl, haloalkyl, aryl, alkylaryl, cycloalkyl, cycloalkylalkyl furyl, furylalkyl, thienyl, thienylalkyl, pyridyl or pyridylalkyl; R 2 and R 4 each is independently hydrogen, lower alkyl, arylalkyl, benzhydryl or ##STR311## wherein R 7 is hydrogen, lower alkyl or phenyl, R 8 is hydrogen, lower alkyl, lower alkoxy or phenyl or R 7 and R 8 taken together are --(CH 2 ) 2 --, --(CH 2 ) 3 --, --CH═CH--, or ##STR312## n is 0 or 1; R 3 is NH 2 (CH 2 ) m --, ##STR313## R 9 is hydrogen, lower alkyl, aryl or arylalkyl, and m is 0 or an integer of from 1 to 5, and --XOR 4 is an imino or amino acid derivative of the formula ##STR314## R 10 is hydrogen, lower alkyl, halogen, keto, hydroxy, ##STR315## a 1- or 2-naphthyl of the formula ##STR316## a 1- or 2-naphthyloxy of the formula ##STR317## or a 1- or 2-naphthylthio of the formula ##STR318## R 11 is keto, halogen, ##STR319## --O--lower alkyl, a 1- or 2-naphthyloxy of the formula ##STR320## or a 1- or 2-naphthylthio of the formula ##STR321## R 12 is keto or ##STR322## R 13 is halogen or --Y--R 23 ; R 20 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; R 21 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy; m 1 is 0 or an integer from 1 to 5; p is 1, 2 or 3 provided that p is more than 1 only if R 20 or R 21 is hydrogen, methyl, methoxy, chloro, or fluoro; R 22 is hydrogen or lower alkyl of 1 to 4 carbons; Y is oxygen or sulfur; R 23 is lower alkyl of 1 to 4 carbons, ##STR323## or the R 23 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a lower alkyl of 1 to 4 carbons or a di(lower alkyl of 1 to 4 carbons) substituent; R 18 is lower alkyl, benzyl, or phenethyl; and R 19 is hydrogen, lower alkyl, benzyl or phenethyl.
Claim 2
Dependent Claim 430 words
A compound of the formula ##STR309## and pharmaceutically acceptable salts thereof, wherein R 1 is lower alkyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, aminoalkyl, furyl, furylalkyl, thienyl, thienylalkyl, pyridyl, pyridylalkyl or ##STR310## and R 5 and R 6 are independently selected from hydrogen, lower alkyl, haloalkyl, aryl, alkylaryl, cycloalkyl, cycloalkylalkyl furyl, furylalkyl, thienyl, thienylalkyl, pyridyl or pyridylalkyl; R 2 and R 4 each is independently hydrogen, lower alkyl, arylalkyl, benzhydryl or ##STR311## wherein R 7 is hydrogen, lower alkyl or phenyl, R 8 is hydrogen, lower alkyl, lower alkoxy or phenyl or R 7 and R 8 taken together are --(CH 2 ) 2 --, --(CH 2 ) 3 --, --CH═CH--, or ##STR312## n is 0 or 1; R 3 is NH 2 (CH 2 ) m --, ##STR313## R 9 is hydrogen, lower alkyl, aryl or arylalkyl, and m is 0 or an integer of from 1 to 5, and --XOR 4 is an imino or amino acid derivative of the formula ##STR314## R 10 is hydrogen, lower alkyl, halogen, keto, hydroxy, ##STR315## a 1- or 2-naphthyl of the formula ##STR316## a 1- or 2-naphthyloxy of the formula ##STR317## or a 1- or 2-naphthylthio of the formula ##STR318## R 11 is keto, halogen, ##STR319## --O--lower alkyl, a 1- or 2-naphthyloxy of the formula ##STR320## or a 1- or 2-naphthylthio of the formula ##STR321## R 12 is keto or ##STR322## R 13 is halogen or --Y--R 23 ; R 20 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; R 21 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy; m 1 is 0 or an integer from 1 to 5; p is 1, 2 or 3 provided that p is more than 1 only if R 20 or R 21 is hydrogen, methyl, methoxy, chloro, or fluoro; R 22 is hydrogen or lower alkyl of 1 to 4 carbons; Y is oxygen or sulfur; R 23 is lower alkyl of 1 to 4 carbons, ##STR323## or the R 23 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a lower alkyl of 1 to 4 carbons or a di(lower alkyl of 1 to 4 carbons) substituent; R 18 is lower alkyl, benzyl, or phenethyl; and R 19 is hydrogen, lower alkyl, benzyl or phenethyl.
Claim 3
Dependent Claim 11 words
The compound as defined in claim 1 wherein n is 0.
Claim 4
Dependent Claim 11 words
The compound as defined in claim 1 wherein n is 1.
Claim 5
Dependent Claim 23 words
The compound as defined in claim 1 wherein R 3 is NH 2 (CH 2 ) m wherein m is 2 to 5.
Claim 6
Dependent Claim 12 words
The compound as defined in claim 1 wherein R 1 is arylalkyl.
Claim 7
Dependent Claim 12 words
The compound as defined in claim 1 wherein X--OR 4 is ##STR324##
Claim 8
Dependent Claim 14 words
The compound as defined in claim 6 wherein R 4 is H or benzyloxy.
Claim 9
Dependent Claim 11 words
The compound as defined in claim 1 having the name (±)-1-[5-amino-2-[hydroxy-(4-phenylbutyl)phosphinyl]-1-oxopentyl]-L-proline.
Claim 10
Dependent Claim 13 words
The compound as defined in claim 1 having the name (±)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]methyl]-1-oxohexyl]-L-proline, benzyl ester.
Claim 11
Dependent Claim 14 words
The compound as defined in claim 1 having the name (±)-1-[6-amino-2-[[hydroxy (4-phenylbutyl)phosphinyl]methyl]-1-oxohexyl]-L-proline, dilithium salt.
Claim 12
Dependent Claim 11 words
The compound as defined in claim 1 having the name (±)-1-[6-acetylamino-2-[[[hydroxy(4-phenylbutyl)phosphinyl]methyl]-1-oxohexyl]-L-proline.
Claim 13
Dependent Claim 13 words
The compound as defined in claim 1 having the name (±)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]methyl]-1-oxohexyl]-L-proline, (2,2-dimethyl-1-oxopropoxy)methyl ester.
Claim 14
Dependent Claim 13 words
The compound as defined in claim 1 having the name (±)-1-[6-amino-2-[[hydroxy(2-phenylethyl)phosphinyl]methyl]-1-oxohexyl]-L-proline, dilithium salt.
Claim 15
Dependent Claim 25 words
A composition useful for treating hypertension comprising a pharmaceutically acceptable carrier and a hypotensive agent as defined in claim 1 or pharmaceutically acceptable salt thereof.
Claim 16
Dependent Claim 21 words
The method of alleviating hypertension in a mammalian specie which comprises administering an effective amount of the composition of claim 14.
Claim 17
Dependent Claim 11 words
The compound as defined in claim 1 having the name (±)-1-[6-amino-2-[[[(2,2-dimethyl-1-oxopropoxy)methoxy](4-phenylbutyl)phosphinyl]methyl]-1-oxohexyl]-L-proline.
Claim 18
Dependent Claim 17 words
The compound as defined in claim 1 having the name (±)-1-[6-amino-2-[[[(2,2-dimethyl-1-oxopropoxy)methoxy](4-phenylbutyl)phosphinyl]methyl]hexyl]-L-proline, (2,2-dimethyl-1-oxopropoxy)methyl ester, 4-methylbenzenesulfonic acid (1:1) salt.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-06-05 1987-12-05 1988-06-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-06-05 1991-12-05 1992-06-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-06-05 1995-12-05 1996-06-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag